- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
- Video and telephone consultations
- Home chemotherapy
Dr Jenner's main clinical interests are the diagnosis and management of haematological malignancies utilising chemotherapy, novel agents and high dose chemotherapy and stem cell transplantation. He leads the myeloma team at UHS with direct responsibility for clinical management of myeloma and paraprotein-related disorders including AL amyloidosis and POEMS syndrome. He runs a weekly all day myeloma clinic for this patient group and accepts referrals both from primary care as well as referrals from other hospitals for specialist input including for clinical trials and transplantation. He also chairs the Central South Coast (Western) Leukaemia and Myeloma multidisciplinary team meeting.
Areas of interest
Myeloma; Plasma cell disorders including AL amyloidosis; Lymphoproliferative disorders; Leukaemia; Haematopoietic stem cell transplantation
Current NHS consultant posts held
Consultant Haematologist at University Hospital Southampton (UHS) NHS Foundation Trust since November 2009.
Haematology Clinical Lead at UHS March 2012 to October 2021.
Associate Care Group Clinical Lead Oncology and Haematology October 2021 to present.
Dr Jenner is principal investigator of a portfolio of myeloma clinical trials encompasing all stages of the disease.
Dr Jenner undertook 4 years of research in to the genetics abnormalities within myeloma at the Institute of Cancer Research and Royal Marsden Hospital between 2005 and 2009. He continues to have an active interest in the role of genetic abnormalities in myeloma and their impact on treatment outcomes.
For full list of publications please see:
Courses offered to GPs
- MBBS Newcastle upon Tyne 1997
- MRCP (UK) Royal College of Physicians of London 2000
- FRCPath Royal College of Pathologists 2008
Reference number 4442130
Details of entry to specialist register
- GMC Specialist Register Haematology , 2009
- Spire Southampton Hospital Chalybeate Close...
- 18:00 - 20:00
- 023 8076 4390
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
Intravenous infusion (as sole procedure) - (5-50)
Spire Southampton Hospital (5-50)
Diagnostic aspiration and trephine biopsy of bone marrow, including analysis - (1-5)